1. A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S−1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG‐M01 study). (13th November 2017) Authors: Ishiguro, Hiroshi; Saji, Shigehira; Nomura, Shogo; Tanaka, Sunao; Ueno, Takayuki; Onoue, Masahide; Iwata, Hiroji; Yamanaka, Takeharu; Sasaki, Yasutsuna; Toi, Masakazu Journal: Cancer medicine Issue: Volume 6:Number 12(2018:Dec.) Page Start: 2909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study. (18th July 2018) Authors: Yamamoto, Yutaka; Iwata, Hiroji; Ueno, Takayuki; Taira, Naruto; Kashiwaba, Masahiro; Takahashi, Masato; Tada, Hiroshi; Tsugawa, Koichiro; Toyama, Tatsuya; Niikura, Naoki; Hara, Fumikata; Fujisawa, Tomomi; Yoshinami, Tetsuhiro; Saji, Shigehira; Takano, Toshimi; Masuda, Norikazu; Morita, Satoshi; T... Journal: Japanese journal of clinical oncology Issue: Volume 48:Number 9(2018) Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial. Issue 1 (January 2021) Authors: Toi, Masakazu; Imoto, Shigeru; Ishida, Takanori; Ito, Yoshinori; Iwata, Hiroji; Masuda, Norikazu; Mukai, Hirofumi; Saji, Shigehira; Shimizu, Akira; Ikeda, Takafumi; Haga, Hironori; Saeki, Toshiaki; Aogi, Kenjiro; Sugie, Tomoharu; Ueno, Takayuki; Kinoshita, Takayuki; Kai, Yuichiro; Kitada, Masahir... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication. Issue 1 (27th February 2019) Authors: Ueno, Takayuki; Saji, Shigehira; Masuda, Norikazu; Iwata, Hiroji; Kuroi, Katsumasa; Sato, Nobuaki; Takei, Hiroyuki; Yamamoto, Yutaka; Ohno, Shinji; Yamashita, Hiroko; Hisamatsu, Kazufumi; Aogi, Kenjiro; Sasano, Hironobu; Toi, Masakazu Journal: ESMO open Issue: Volume 4:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Issue 1 (December 2016) Authors: Uehiro, Natsue; Sato, Fumiaki; Pu, Fengling; Tanaka, Sunao; Kawashima, Masahiro; Kawaguchi, Kosuke; Sugimoto, Masahiro; Saji, Shigehira; Toi, Masakazu Journal: Breast cancer research Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy. Issue 1 (December 2016) Authors: Ueno, Takayuki; Saji, Shigehira; Sugimoto, Masahiro; Masuda, Norikazu; Kuroi, Katsumasa; Sato, Nobuaki; Takei, Hiroyuki; Yamamoto, Yutaka; Ohno, Shinji; Yamashita, Hiroko; Hisamatsu, Kazufumi; Aogi, Kenjiro; Iwata, Hiroji; Imoto, Shigeru; Sasano, Hironobu; Toi, Masakazu Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development of Breast Cancer Therapy: Biomarker-Driven and Response-Guided Approaches in a Neoadjuvant Setting. Issue 2 (April 2015) Authors: Toi, Masakazu; Masuda, Norikazu; Ishiguro, Hiroshi; Saji, Shigehira; Ohno, Shinji; Chow, Louis W.C. Journal: International journal of biological markers Issue: Volume 30:Issue 2(2015) Page Start: 252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy. Issue 1 (December 2015) Authors: Honma, Naoko; Horii, Rie; Ito, Yoshinori; Saji, Shigehira; Younes, Mamoun; Iwase, Takuji; Akiyama, Futoshi Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial. (17th November 2022) Authors: Iwata, Hiroji; Nakamura, Rikiya; Masuda, Norikazu; Yamashita, Toshinari; Yamamoto, Yutaka; Kobayashi, Kokoro; Tsurutani, Junji; Iwasa, Tsutomu; Yonemori, Kan; Tamura, Kenji; Aruga, Tomoyuki; Tokunaga, Eriko; Kaneko, Koji; Lee, Min-Jung; Yuno, Akira; Kawabata, Azusa; Seike, Toshihiro; Kaneda, Ayum... Journal: Japanese journal of clinical oncology Issue: Volume 53:Number 1(2023) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of a novel medical device for pegfilgrastim administration. Issue 5 (29th March 2022) Authors: Aruga, Tomoyuki; Doihara, Hiroyoshi; Yanagita, Yasuhiro; Ishida, Takanori; Yamashita, Toshinari; Uehara, Kanou; Taira, Tetsuhiko; Tsurutani, Junji; Takeshita, Takashi; Tsuyuki, Shigeru; Kaneko, Koji; Ohtake, Tohru; Yamaguchi, Yusuke; Hara, Yui; Saji, Shigehira Journal: Cancer science Issue: Volume 113:Issue 5(2022) Page Start: 1763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗